1-fluoro-7-iodoheptane | CAS:1189187-98-1

We serve 1-fluoro-7-iodoheptane CAS:1189187-98-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-fluoro-7-iodoheptane

Chemical Name:1-fluoro-7-iodoheptane
CAS.NO:1189187-98-1
Synonyms:1-fluoro-7-iodoheptane
Molecular Formula:C7H14FI
Molecular Weight:244.091063
 
Physical and Chemical Properties:
Density:1.5±0.1
Melting point:ºC
Boiling point:1.5±0.1ºC
Flash point:1.5±0.1ºC
Index of Refraction:1.477
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.05%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1-fluoro-7-iodoheptane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-fluoro-7-iodoheptane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-fluoro-7-iodoheptane Use and application,1-fluoro-7-iodoheptane technical grade,usp/ep/jp grade.


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.2-Acetyl-1-ethylpyrrole manufacturer The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.DL-1,2-Isopropylideneglycerol supplier The API is not made by only one reaction from the raw materials but rather it becomes an API via several chemical compounds.Methyl 2-(chlorosulfonylmethyl)benzoate vendor According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.